Skip to main content
Log in

Development of plasma cell tumors during treatment of multiple myeloma

  • Original Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Abstract

Plasma cell tumors (plasmacytomas-PCT) of the bone, or extramedullary PCT, may be diagnosed in patients with or without the diagnostic criteria for systemic multiple myeloma (MM). The reason for the local development of these tumors is not clear. Recent reports emphasize the contribution of CT and MRI in the detection of bone lesions and their expansion into the soft tissues. We report the development of PCT in nine patients with MM under maintenance treatment with α-IFN, of whom six had no evidence of systemic relapse and three had indications of early relapse. The PCT were located in the pelvis (4), thoracic (3), cervical (1), and lumbar (2) spine and in 8/9 cases were not demonstrable on plain X-rays. These observations suggest that frequent screening with advanced imaging techniques may detect local disease expansion in asymptomatic patients. Early application of radiochemotherapy may improve prognosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Barlogie B, Epstein J, Selvanayagam P, Alexanian R (1989) Plasma cell myeloma — new biological insights and advances in therapy. Blood 73: 865–879

    PubMed  CAS  Google Scholar 

  2. Caligaris-Cappio F, Bergui L, Gregoretti MG, Gaidano G, Gaboli K, Schena M, Zallone A, Marchisio P (1991) Role of bone marrow stromal cells in the growth of human multiple myeloma. Blood 77: 2688–2693

    PubMed  CAS  Google Scholar 

  3. Durie B (1982) Staging and kinetics of multiple myeloma. Clin Haematol 11: 3–18

    PubMed  CAS  Google Scholar 

  4. Grander D, von Stedingk LV, von Stedingk M, Wasserman J, Einhorn S (1991) Influence of interferon on antibody production and viability of malignant cells from patients with multiple myeloma. Eur J Haemtol 46: 17–25

    Article  CAS  Google Scholar 

  5. Kyle R, Schreiman J, McLeod R, Beabout J (1985) Computed tomography in diagnosis and management of multiple myeloma and its variants. Arch Intern Med 145: 1451–1452

    Article  PubMed  CAS  Google Scholar 

  6. Ludwig H, Tsolacoff D, Neyhold A, Fruhwald F, Rasoul S, Fritz E (1987) Magnetic resonance imaging of the spine in multiple myeloma. Lancet II: 364–366

    Article  Google Scholar 

  7. Mandelli F, Tribalto M, Avvisati G, Cantonetti M, Petrucci MT, Boccadoro M, Pilery A, Marmont F, Resengotti L, Lauta V, Dammacco F (1988) Recombinant interferon alpha-2b (Intron A) as postinduction therapy for responding multiple myeloma patients. M84 protocol. Cancer Treat Rev 15 [Suppl A]: 43–48

    Article  PubMed  Google Scholar 

  8. Moulopoulos L, Granfield C, Dimopoulos M, Kim E, Alexian R, Libshitz H(1993) Extraosseous multiple myeloma: imaging features. Am J Radiol 161: 1083–1087

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vaiopoulos, G., Viniou, N., Plata, E. et al. Development of plasma cell tumors during treatment of multiple myeloma. Ann Hematol 72, 317–320 (1996). https://doi.org/10.1007/s002770050178

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s002770050178

Key words

Navigation